Dr Julian Taylor and Ali Gibson
Stoke Mandeville Spinal Research
Dr. Julian Taylor: Julian directs studies focused on sensorimotor dysfunction after spinal cord injury, including spasticity, neuropathic pain and mechanisms of activity based rehabilitation at Stoke Mandeville Spinal Research and at the Hospital Nacional de Parapléjicos in Spain. He is member of the Society for Neuroscience (1990), IASP (2001) and ISCOS (2015).
Ali sustained a spinal cord injury in 1996. She went on to study at the University of Nottingham and graduated in 2006 with a first class honours in Psychology.
Ali is passionate about peer support and maximizing the outcomes of rehabilitation following spinal cord injury and other long-term neurological conditions. She has proven experience of academic and clinical research, clinical trial management, peer support, mentoring and public speaking.
Having first-hand experience of living with the impact of spinal cord injury, Ali is committed to supporting research that aims to improve people’s quality of life following spinal cord injury. In her current position as Community Liaison Officer for Stoke Mandeville Spinal Research (SMSR), she works closely with key stakeholders and in the community to raise awareness of living with spinal cord injury and to discuss the research that that is being undertaken by SMSR.
Spinal Cord Injury Spasticity: a research update on symptoms
Spasticity is an important sensorimotor disorder that affects more than 60% of people with spinal cord injury (SCI). Although the standard diagnosis of the SCI spasticity syndrome has traditionally relied on the measurement of muscle rigidity, the assessment of other symptoms such as involuntary muscle spasms and cutaneous hyperreflexia may also provide an insight into how spasticity can affect residual motor function and activities of daily life (ADL). In this lecture the importance of characterising different spasticity symptoms in relation to understanding their negative and positive impact on residual neuromuscular function will be discussed. The impact of SCI symptoms on neuromuscular function and ADL will also be described by our Community Liaison Officer who has first-hand experience of spasticity. Finally, the possibilities of how new neurorehabilitation technologies can contribute to the management of spasticity symptoms will be also be discussed.
EVEN MORE SEMINARS
Dr Cheryl Metcalf University of Southampton
Commericalising health technologies
Andrew Fahey Brookson Direct
The Impact of IR35 on the NHS
Bethel Osuagwu, Derek Jones Stoke Mandeville Spinal Research
Assessment of the orthotic and long-term functional gain of the SEM Glove in people with chronic spinal cord injury
Dr Anne Wright Evelina London Children’s Hospital, Guy’s and St Thomas’ NHS foundation Trust
Neuromodulation for Incontinence in Children
Dr Julian Taylor, Miguel Rodriguez, Dr. Armin Schnürer Gtec & Advanced Medical Equipment
The DolSCI Network: Harnessing Expertise for Better Neuropathic Pain Control